SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-030760
Filing Date
2024-08-08
Accepted
2024-08-08 16:06:37
Documents
74
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1940516
2 ex31-1.htm EX-31.1 17360
3 ex31-2.htm EX-31.2 17440
4 ex32-1.htm EX-32.1 7291
5 ex32-2.htm EX-32.2 7620
  Complete submission text file 0001493152-24-030760.txt   8293105

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE orgs-20240630.xsd EX-101.SCH 58911
7 XBRL CALCULATION FILE orgs-20240630_cal.xml EX-101.CAL 82964
8 XBRL DEFINITION FILE orgs-20240630_def.xml EX-101.DEF 268173
9 XBRL LABEL FILE orgs-20240630_lab.xml EX-101.LAB 439397
10 XBRL PRESENTATION FILE orgs-20240630_pre.xml EX-101.PRE 352834
76 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1469424
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38416 | Film No.: 241188232
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)